GILD Stock UPDATES Gilead Sciences (GILD) 107.56 09/02/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gilead Sciences (GILD) 107.56 $GILD

3 Simple Ways to Invest Like George Soros
George Budwell, The Motley Fool - Motley Fool - Sat Aug 30, 10:42AM CDT
Source: Wikimedia commons Before investing a single penny, you should have some type of overarching strategy or philosophy as a guide. Most commonly, the average investor turns to Warren Buffett in the hope of cracking Wall Street's secret code....

Regeneron Pharmaceuticals' Pipeline Progress Raises Costs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 5:30PM CDT
Regeneron (REGN) expects adjusted SG&A costs to rise further in the remaining quarters of 2014.

Pfizer's C. Difficile Vaccine Gets Fast Track Status - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 5:10PM CDT
Pfizer Inc. (PFE) announced that its vaccine candidate for clostridium difficile infection has been granted fast track designation by the FDA.

Final Glance: Biotechnology companies
AP - Fri Aug 29, 5:07PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:

Intellipharmaceutics' Oxycodone Program to Prevent Overdose - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 4:10PM CDT
Intellipharmaceutics (IPCI) upgraded its Rexista oxycodone development program.

Protalix/Pfizer's Elelyso Approved in Pediatric Patients - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 4:00PM CDT
Protalix (PLX) and Pfizer (PFE) announced that the FDA has approved Elelyso injection for pediatric patients suffering from type I Gaucher disease.

Isis Pharmaceuticals Starts Phase III Study on ISIS-APOCIIIRx - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 3:55PM CDT
Isis Pharmaceuticals, Inc. (ISIS) has initiated a phase III study which will evaluate the use of ISIS-APOCIIIRx.

Momenta-Sandoz's Generic Copaxone Accepted for Review by FDA - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 2:20PM CDT
Momenta Pharmaceuticals (MNTA) announced that the FDA has accepted Sandoz's abbreviated new drug application for generic Copaxone for review.

Midday Glance: Biotechnology companies
AP - Fri Aug 29, 12:19PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:

4 Biotechs That Might Be Bought Soon
at Investor's Business Daily - Fri Aug 29, 10:53AM CDT
The recent announcement that Roche (RHHBY) will buy InterMune (ITMN) for $8.3 billion brought new life to M&A speculation in the biotech industry, which had been relatively neglected as the buzz focused on tax-inversion deals by biopharmaceutical...

Early Glance: Biotechnology companies
AP - Fri Aug 29, 9:31AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:

Protalix BioTherapeutics, Inc. (PLX) Jumps: Stock Adds 8.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 8:11AM CDT
Protalix BioTherapeutics, Inc. (PLX) was a big mover last session, as the company saw its shares rise by over 8% on the day.

Why Gilead Sciences (GILD) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 7:53AM CDT
Positive earnings estimate revisions suggest that analysts are becoming more optimistic on Gilead Sciences’s earnings for the coming quarter and year.

OncoMed Pharmaceuticals (OMED) in Focus: Stock Up 9.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 29, 7:51AM CDT
OncoMed Pharmaceuticals, Inc. (OMED) was a big mover last session, as its shares rose nearly 10% on the day.

Has Gilead Sciences, Inc.'s Star Drug Already Peaked?
Brian Orelli, The Motley Fool - Motley Fool - Thu Aug 28, 7:00PM CDT
Gilead Sciences ' hepatitis C drug scored $3.5 billion in sales in the second quarter, but prescriptions have been falling since before the quarter closed. First, new prescriptions started to fall in March. And then, as you'd expect, total...

Bristol-Myers' Oral HCV Treatment Daklinza Gets EU Clearance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 28, 5:50PM CDT
Bristol-Myers' (BMY) Daklinza has been cleared in the EU.

RedHill Expands ERADICATE Study on RHB-105 for H. pylori - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 28, 5:40PM CDT
RedHill Biopharma Ltd. (RDHL) recently provided an update on the ongoing phase III study ERADICATE Hp, on pipeline candidate RHB-105 for Helicobacter pylori infection (H. pylori).

Amgen's Chronic Heart Failure Drug Gets Priority Review - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 28, 5:20PM CDT
Amgen Inc. (AMGN) received encouraging news from the FDA as the regulatory body granted priority review status to the New Drug Application (NDA) for its pipeline candidate, ivabradine.

Most active Nasdaq-traded stocks
AP - Thu Aug 28, 5:02PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Highway 99 Truck Death Puts Safety Records in Focus

Updated Category News Views 72

A stopped car on a highway shoulder is supposed to be a bad day, not a death sentence. Yet on November 5, 2026, a person helping a relative with a disabled vehicle was killed on northbound Highway 99 in Elk Grove after a commercial tractor-trailer allegedly drifted onto the shoulder, hit both stationary vehicles, and overturned. Northbound lanes were closed for hours. A...

Continue Reading
Leatt Sets Its Virtual 2026 Shareholder Meeting Date

Updated Category News Views 73

A calendar notice is not a catalyst, but ignoring the calendar is how shareholders miss the small moments that matter. Leatt Corporation has scheduled its 2026 virtual annual general meeting of stockholders for Friday, November 20, at 11:00 AM Eastern Time. For holders of OTCQB:LEAT, this is a basic corporate-governance event, not a new product launch or a financial...

Continue Reading
Roland DG's Brand Refresh Earns Three B2B Awards in 2026

Updated Category News Views 98

Three trophies for a printer-maker’s marketing overhaul will not move mountains by themselves, but they do tell us Roland DG has stopped treating its brand like an afterthought. The company’s global Make Your Mark refresh picked up two Silver awards and one Bronze at the 2026 Drum B2B Awards in Miami. For a business selling industrial-grade tools into crowded,...

Continue Reading
Devicie Broadens Browser Security Across Device Fleets

Updated Category News Views 57

Browsers have quietly become the front door, side door, and occasionally the busted basement window of corporate security. Devicie’s newly expanded Edge for Business Reporting Connector tackles that uncomfortable reality by pulling browser security events from Windows, macOS, iOS, and Android into the same console customers use to oversee Microsoft Intune environments....

Continue Reading
BKV Energy's $400,000 Loyalty Bet Has a Real Point Behind It

Updated Category News Views 92

Retail power customers rarely send thank-you notes; they switch plans, complain about bills, or quietly vanish. That is why BKV Energy putting more than $400,000 into its third annual ElectroShare payout deserves a harder look than the usual feel-good loyalty announcement. A Retention Expense With Some Teeth The payout has climbed quickly: roughly $113,000 in the first...

Continue Reading
MetaOptics Tests a Real Path Into Secure Imaging Markets

Updated Category News Views 77

Fingerprint scanners have never impressed me much; fooling one is exactly the sort of nuisance that keeps security buyers spending. MetaOptics’ new collaboration with Hong Kong’s ASTRI goes after that uncomfortable problem with a compact nano-optics imaging system built for biometric security and smart sensing. It is a sensible target. It is also, at this stage, a...

Continue Reading
Sinopec’s Algerian Outreach Reveals a Patient Long Game

Updated Category News Views 109

Soft Power Does Not Run a Refinery, but It Matters A short video contest in Algiers will not move an oilfield schedule or settle a hydrocarbons negotiation. That is precisely why this Sinopec-backed event deserves a sober look rather than a chest-thumping one. On Nov. 15, Sinopec Group and the Chinese Embassy in Algeria co-hosted the final of their second youth cultural...

Continue Reading
Freedom Debt Relief Earns Service Recognition in 2026

Updated Category News Views 48

A Service Badge Carries Weight in a Rough Business Debt settlement is not a business where a pleasant phone voice alone gets the job done. People arrive carrying unsecured balances, anxiety, and usually a fair amount of distrust. That is why CNBC Select naming Freedom Debt Relief its “Best for Customer Service” is more meaningful than the usual chest-thumping...

Continue Reading
Century Complete Tests Conway Demand Near Myrtle Beach

Updated Category News Views 96

Ninety-four lots in Conway may not move Wall Street by themselves, but they can say plenty about the kind of buyer Century Communities is chasing. Century Complete is opening its model at Cates Bay Crossing on Nov. 21, 2026, with single-family homes starting in the $260s. In a housing market where affordability gets talked to death and rarely delivered cleanly, that...

Continue Reading
DigiKey’s Arduino Webinar Puts Edge AI Hardware to Work

Updated Category News Views 87

A Small Board With a Big Practical Question Edge AI is finally getting dragged out of the slide deck and onto the workbench, which is where it ought to prove itself. DigiKey plans to host a free 60-minute webinar on Dec. 2, 2026, at 10 a.m. CST covering Arduino’s new VENTUNO Q edge AI computer. The session promises a hardware tour, an Arduino App Lab walkthrough, and a...

Continue Reading

Top 5 Most Recently Viewed Articles

Jordyn Poulter Shines in Times Square After Olympic Success

Updated Category News Views 419

Jordyn Poulter Shines in Times Square After Olympic Success Attention volleyball fans and supporters of women's sports: professional women's volleyball has officially made its mark in the United States. Today, a stunning billboard featuring Olympic silver medalist Jordyn Poulter was unveiled in the bustling Times Square of New York City. Poulter previously played for UYBA...

Continue Reading
Lifecore Biomedical Plans Exciting Financial Update Soon

Updated Category News Views 260

Lifecore Biomedical Prepares to Share Financial Insights Lifecore Biomedical, Inc. (NASDAQ: LFCR) is gearing up to share its financial outcomes for the second quarter of fiscal year 2025 in early January. This exciting announcement marks a significant moment for the company, which is known for its expertise in the contract development and manufacturing landscape. What to...

Continue Reading
Peloton Interactive, Inc. Sets Earnings Call for Q1 of 2025

Updated Category News Views 86

Peloton Interactive, Inc. Earnings Call Announcement Peloton Interactive, Inc. (NASDAQ: PTON) is gearing up for an important announcement regarding its financial results. The company will share its first quarter fiscal 2025 results before the stock market opens on a Thursday in late October. This is a key moment for both the company and its investors, as it lays out the...

Continue Reading
Centerspace Boosts Core FFO Guidance Amid Market Challenges

Updated Category News Views 159

Centerspace's Successful Third Quarter Performance Centerspace (NYSE: CSR), a prominent real estate investment trust, reported a strong third quarter performance in 2024 during its recent earnings call. The company announced a core funds from operations (FFO) of $1.18 per share, reflecting a notable 3% rise in same-store revenue, alongside an improved occupancy rate of...

Continue Reading
Ammunition Depot Crowned as Leading Online Ammo Retailer

Updated Category News Views 277

Ammunition Depot Crowned as Leading Online Ammo Retailer Ammunition Depot has been recognized as the best online destination for purchasing ammunition, according to a recent feature in Guns & Ammo Magazine. This accolade highlights their dedication to delivering a remarkable customer experience complemented by fast shipping and extensive product offerings. In a detailed...

Continue Reading